News


MEDiC Life Sciences Announces Collaboration with Hanmi Pharmaceutical (128940.KS) on Biomarker Discovery for Hanmi’s Clinical Asset (Jul. 2024)


MEDiC Life Sciences Announces Collaboration with Pharos iBio (388870, KOSDAQ) on First-in-class Oncology Drug Development (Apr. 2024)


MEDiC has successfully raised $8 million in its Seed funding rounds, closed in summer 2023, backed by a diverse group of investors, including Top Harvest Capital, Primer Sazze Partners, Illumina Accelerator, Big Basin Capital, First In Ventures, and Wing Venture Capital.


MEDiC Life Sciences Announces Collaboration with Bristol Myers Squibb on Tumor Target Discovery (June, 2023)


Illumina Accelerator welcomes MEDiC Life Sciences Inc. as one of the first global cohort of genomics startups (June, 2020)


Medic_Grand_prize.jpg

MEDiC received the Grand Prize during the 11th SF Funding Cycle of Illumina Accelerator.

The Prize was awarded to the startup that generates the most data out of all Illumina Accelerator genomics startups. MEDiC set the new record by producing 34Tbs of WGS data from patient-derived cancer organoids.


MEDiC was featured as one of Translational Genomics Innovators in the event hosted by J&J Innovation (Advances in Drug Discovery, May, 2021)


Our Nature paper was featured as the representative discovery platform for novel cancer drug targets in "The Conversation" (April, 2021)

News